Search
for
Sort by
Research 271–300 of 452
- Quality of life in children and adolescents with alopecia areata—A systematic review
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Alopecia after injection of ATX-101 for reduction of submental fat
- Photobiomodulation for the management of hair loss
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals
- Epidermis reconstructed from the outer root sheath of human hair follicle. Effect of retinoic acid
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Bullying in persons with skin diseases
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Health‐related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Third International Research Workshop on Alopecia Areata
- A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
- Prevalence and associated factors of skin cancer in aged nursing home residents: A multicenter prevalence study
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Research-based findings on scope of liposome-based cosmeceuticals: an updated review